ABSTRACT
Introduction
Elderly individuals are a heterogeneous population, and many of them have several chronic illnesses that require multiple medications, making them vulnerable to adverse drug events that contribute to elevated medical costs but are preventable (Zhang et al., 2009). Appropriate pharmaceutical care for the elderly has been determined based on clinical trials conducted with younger adults. However, because of changes in pharmacokinetics and pharmacodynamics associated with aging, greater attention is needed in pharmacy management for patients aged >65 years (Akazawa et al., 2010).
Factors such as age-related changes in drug pharmacokinetics and pharmacodynamics complicate medication prescribing. In addition, the presence of multiple co-morbidities and the consequent prescribing of many concurrent medications increase the likelihood of other problems, such as drug interactions, failure to adjust doses in the elderly, failure to monitor and review medication, unnecessary prescribing and problems with medication management in the home (Basger et al., 2008).
People over the age of 65 years have a higher prevalence of chronic illness, disability and dependency than those <65 years. They are more likely to be on medication than younger people. They are often taking several drugs at once to treat concomitant disease processes (Gallagher et al., 2007).
Geriatricians are trained, when faced with an older individual presenting with multiple different symptoms, to consider several diagnoses rather than a single unifying diagnosis. Most very elderly patients do have several concomitant chronic conditions (Fortin et al., 2005; Marengoni et al., 2008). Hypertension, heart failure, stable angina, atrial fibrillation, hypercholesterolemia, diabetes, osteoarthritis, chronic obstructive lung disease, and osteoporosis, as well as dementia and depression represent the most frequent chronic diseases encountered in the geriatric population (Zhang et al.,
2010; Stevens et al., 2010).
Presenting with multiple comorbidities is associated with diminished quality of life, physical disability, psychological disorders, increased use of health care resources, multiple health care providers, poly-medication and an overall increased risk of adverse events (Budnitz et al., 2006; Lang et al., 2010). All of these factors influence the riskbenefit ratio of drug therapy and other treatments. Elderly patients with multiple comorbidities must generally master self-management tasks, a process influenced not only by the disease burden or level of morbidity, but also by specific psychosocial factors (Vogt-Ferrier, 2011).
Older subjects use a higher number of drugs than younger ones, to treat a higher number of conditions. Poly-pharmacy is frequent in this population, and this carries an increased risk of medication-related problems, including adverse drug reactions (ADRs) and drug-drug interactions (Juurlink et al., 2003) . Susceptibility to suffer these problems increases with age for a number of reasons, including age-related changes in pharmacokinetics and pharmacodynamics, poly-pharmacy, comorbidity, disability, social aspects, and the exclusion of the oldest, frailest patients from drug research (Conejos et al., 2010).
In the United States, 12.5%of the population is over 65 years of age but consume 32% of all prescription medications and account for 25% of drug expenditure and 30% of total national healthcare expenditure (Gupta et al., 1996; Golden et al., 1999). In Ireland, people over the age of 65 years comprise 11.13% of the population but consume 47% of all prescription medications (Barry, 2002) . In Europe, people over 65 years of age consume on average 2.3 times the amount of health care than do those <65 years of age (Masoodi, 2008) . These figures indicate that older people are the greatest consumers of medications and healthcare resources in developed countries. Population demographics are changing worldwide, with life expectancy and the proportions of older persons increasing. It is reasonable to assume that as more drugs become available and longevity continues to increase, the consumption of prescription drugs by older people will increase further and the incidence of potentially inappropriate prescribing will grow (Gallagher et al., 2007).
The use of several drugs concomitantly is justified in the treatment of multiple chronic diseases. However, poly-pharmacy is known to dramatically increase the risk of ADRs, drug-drug and drug-disease interactions ( . It has been claimed that patients taking two drugs face a 13% risk of adverse drug interactions, rising to 38%when taking four drugs and to 82% if seven or more drugs are given simultaneously (Goldberg et al., 1996). With poly-pharmacy, duplicative prescribing within the same drug class is prevalent and unrecognized drug adverse-effects are often treated with more drugs thus leading to prescribing cascades, e.g. using levodopa to treat the Parkinsonian adverse-effects of neuroleptic medications. Poly-pharmacy also makes compliance with medications more challenging. Non-compliance with prescribed medications can result in sub-optimal therapeutic effectiveness and can have major clinical consequences (Monane et al., 1997). If the existence of non-compliance is not recognized, the physician may increase the dose of the initial medication or add a second agent, increasing both the risk and the cost of treatment (Gallagher et al., 2007).
The hospitalized patients -who often receive multiple medications -are likely to be the victims of a prescribing cascade which leads to an increased likelihood of receiving inappropriate drug therapy (Tiwari and Kapur, 2007). Hence, the aim of current study was to identify and classify different types of drugs and comorbid diseases encountered among hospitalized elderly patients.
Patients and methods

Study subjects
Data were prospectively collected from 320 patients aged ≥ 65 hospitalized at the Department of Geriatrics and Gerontology at a university teaching hospital in Egypt among 17 month study period. All patients admitted to the geriatric department whether at the critical care area or hospital inpatients wards were assessed for eligibility according to the following criteria:
Inclusion Criteria
All hospital inpatients aged ≥65 years old were included in the study irrespective their medical condition.
Exclusion Criteria
Patients previously included in the study and are being admitted to the hospital for the second time.
Data collection
The patient data were collected with the help of consultants and senior residents at the Department of Geriatric Medicine at the time of hospital admission. The collected patient's medical data include basic demographic characteristics (age, sex), medical history, problem list, medical co-morbidities and concurrent medications. This clinical data was collected from medical records directly in wards, because the electronic medical reports were unavailable.
Supplementary information was obtained from the patient, geriatric resident and hospital record when necessary, e.g. precise dose and duration of therapy, analgesic history, baseline renal function and blood pressure profile.
Assessed parameters
Patient's medical profiles were studied carefully for identification and classification of different types of drugs and comorbid diseases encountered among hospitalized elderly patients.
Statistical analysis
Continuous variables were expressed as means ± S.D., and categorical variables were expressed as frequencies and percentages.
Results
Patients' demographics are presented in Table ( 1). Out of the 320 patients analyzed, the majority of patients (70.6%) belonged to the age group of 65-74 years, while 19.7% were in the age group of 75-84 years and only 9.7% were over 84 years of age.
In current study, there were different types of comorbid diseases encountered among the patients, with a median of five per patient and a range of 1-11 per patient. Patients with 3 to 6 comorbid diseases comprised 70% of the total number of patients. The most common medical disorders among the studied patients were hypertension (52.8%), diabetes (42.5%), chronic liver diseases (40.3%) and ischemic heart diseases (34.1%). Table ( 2) presents the number and different types of morbidities encountered among the studied elderly patients.
A total of 2985 medications were prescribed for these 320 elderly patients, with a median of nine per patient and a range of 2-20 per patient. Approximately 75% of patients took seven medications and more, but only 8.4% took fewer than five medications. Table (3)  Table ( 4) represents the different drug classes administered to patients. The most commonly prescribed medications were antacids and peptic ulcer medications (78.1%), antiplatelet and anticoagulants (77.2%), antibiotics (68.1%) and antihypertensive drugs (67.2%). While the less frequently prescribed drugs were skeletal muscle relaxant (0.6%), thyroid hormones (0.6%) and antifungal drugs (0.3%). Table ( 5) showed that the most frequently used groups of antihypertensive drugs were diuretics followed by ACE inhibitors. 
Discussion
As the population ages, medical practice has to attend to the special needs inherent to the care of elderly patients. Because of the decline in the physiologic functions, the elderly patients are more vulnerable to drug-related problems; about half of which are known to be preventable (Gurwitz et al., 2003) . Moreover, the longer one's life is, the more chronic the medical conditions one may accumulate and therefore, a larger number of drugs are needed for the treatment of ailments in geriatric patients (Chang et al., 2004 ).
In the current study, there was a nearly equal proportion of male to female elderly patients. The number of morbidities ranged from (1-11) per patient and more than 75% of the patients were suffering from ≥4 diseases (poly-morbidity).
The most common medical disorders observed in the studied elderly patients were hypertension (10.1%) followed by diabetes (8.1%), chronic liver diseases (7.7%) and ischemic heart diseases (6.5%), which is consistent with the study of Stanford and colleagues that documented hypertension and ischemic heart diseases to be the most common morbidities among their studied elderly patients (Stafford et al., 2011) .
In the present study, the mean number of prescribed medications was 9.3, with approximately 75% of patients receiving ≥7 medications. On the contrary, other studies have documented lower means (Liu et al., 2012; García-Gollarte et al., 2012) . On the other hand, our mean was lower than that of the study of Pyszka and colleagues that reported a mean number of 12.9 medications on admission, 14.2 on discharge and 14.1 during follow-up, indicating that poly-pharmacy is generally common among the elderly population (Pyszka et al., 2010) . Hence, reducing the number of medications, despite being worthwhile, should not be the main target in improving drug safety in the elderly. Poly-pharmacy is sometimes unavoidable and can be appropriate when it is carefully managed and monitored.
The university hospital are usually considered tertiary referral hospital who admit cases in advanced stages. In the current study, the most commonly prescribed medications were antacids and peptic ulcer medications (78.1%), antiplatelet and anticoagulant (77.2%), antibiotics (68.1%) and antihypertensive drugs (67.2%). In contrast, Stafford and colleagues reported that the most commonly prescribed medications in their sample were: analgesics and antipyretics (56.8%), antithrombotic agents (52.7%), drugs for peptic ulcer and gastro-esophageal reflux disease (43.8%), antidepressants (36%) and high-ceiling diuretics (30.8%) (Stafford et al., 2011) . The difference between these results and ours can be attributed to the difference in disease prevalence and distribution amongst different countries.
Prescribing appropriately for older patients is complex, and there is a wide variation in experience with geriatric pharmacotherapy among physicians of all specialties and levels (Gallagher et al., 2011).
Conclusion
Older people are a heterogeneous group, often with multiple co-morbidities and multiple prescriptions of many concurrent medications which increase the likelihood of other problems, such as drug interactions, failure to adjust doses in the elderly, failure to monitor and review medication, unnecessary prescribing. Pharmacist's interventions are very important to improve the quality of life of the elderly patients which may be performed by studying drugs' information, collecting patients' data including the study of each patient's history and patients' data evaluation for the presence of any drug related problems and medication errors.
